{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:29:59Z","timestamp":1792542599976,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004619","name":"JAXA ISAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015103","name":"Japan Racing Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.compbiomed.2024.109236","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:06:49Z","timestamp":1728295609000},"page":"109236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Molecular modelling and experimental validation identified a new therapeutic inhibitor of toxoplasmosis"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9342-8505","authenticated-orcid":false,"given":"Oluyomi Stephen","family":"Adeyemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilayo","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobiloba","family":"Maduakolam-Aniobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.compbiomed.2024.109236_bib1","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/microorganisms9091960","article-title":"Promising drug targets and compounds with anti-Toxoplasma gondii activity","volume":"9","author":"Silva","year":"2021","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.compbiomed.2024.109236_bib2","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/pharmaceutics14081634","article-title":"Drug repurposing based on Protozoan proteome: in vitro evaluation of in silico screened compounds against Toxoplasma gondii","volume":"14","author":"Cajazeiro","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.compbiomed.2024.109236_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-09015-7","article-title":"Human Toxoplasma gondii infection in Nigeria: a systematic review and meta-analysis of data published between 1960 and 2019","volume":"20","author":"Karshima","year":"2020","journal-title":"BMC Publ. Health"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13071-020-04094-2","article-title":"Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain","volume":"13","author":"Liu","year":"2020","journal-title":"Parasites Vectors"},{"issue":"2","key":"10.1016\/j.compbiomed.2024.109236_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1017\/S0031182017001901","article-title":"The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug design","volume":"145","author":"Cardew","year":"2018","journal-title":"Parasitology"},{"issue":"14","key":"10.1016\/j.compbiomed.2024.109236_bib6","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.3390\/molecules26144203","article-title":"A novel calcium-dependent protein kinase 1 inhibitor potently prevents Toxoplasma gondii transmission to foetuses in mouse","volume":"26","author":"Debare","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.compbiomed.2024.109236_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ijpara.2017.12.006","article-title":"Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis","volume":"48","author":"Moine","year":"2018","journal-title":"Int. J. Parasitol."},{"issue":"24","key":"10.1016\/j.compbiomed.2024.109236_bib8","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1021\/acs.jmedchem.7b01192","article-title":"Inhibition of calcium dependent protein kinase 1 (CDPK1) by pyrazolopyrimidine analogs decreases establishment and reoccurrence of central nervous system disease by Toxoplasma gondii","volume":"60","author":"Rutaganira","year":"2017","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.compbiomed.2024.109236_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.compbiomed.2024.109236_bib10","first-page":"420","article-title":"Natural products as reservoirs of novel therapeutic agents","volume":"17","author":"Mushtaq","year":"2018","journal-title":"EXCLI journal"},{"key":"10.1016\/j.compbiomed.2024.109236_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/B978-0-12-820472-6.00041-4","article-title":"The role of natural products as sources of therapeutic agents for innovative drug discovery","author":"Dzobo","year":"2022","journal-title":"Comprehensive pharmacology"},{"issue":"3","key":"10.1016\/j.compbiomed.2024.109236_bib12","first-page":"369","article-title":"In vitro screening to identify anti-toxoplasma compounds and in silico modeling for bioactivities and toxicity","volume":"92","author":"Adeyemi","year":"2019","journal-title":"Yale J. Biol. Med."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.109236_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00436-017-5698-1","article-title":"Screening of chemical compound libraries identified new anti-Toxoplasma gondii agents","volume":"117","author":"Adeyemi","year":"2018","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.compbiomed.2024.109236_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.907583","article-title":"A computational approach to elucidate the interactions of chemicals from artemisia annua targeted toward SARS-CoV-2 main protease inhibition for COVID-19 treatment","volume":"9","author":"Johnson","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.compbiomed.2024.109236_bib16","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.compbiomed.2024.109236_bib17","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2051","article-title":"Protocol for molecular dynamics simulations of proteins","volume":"6","author":"Gajula","year":"2016","journal-title":"Bio-protocol"},{"issue":"10","key":"10.1016\/j.compbiomed.2024.109236_bib18","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"12","key":"10.1016\/j.compbiomed.2024.109236_bib19","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1007\/s00436-013-3608-8","article-title":"Effects of dextran sulfates on the acute infection and growth stages of Toxoplasma gondii","volume":"112","author":"Ishiwa","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.compbiomed.2024.109236_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2147\/IJN.S122178","article-title":"Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential","volume":"12","author":"Adeyemi","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.compbiomed.2024.109236_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114597","article-title":"L-tryptophan-titanium oxide nanoparticles showed selective anti-Toxoplasma gondii activity and improved host biocompatibility","volume":"162","author":"Adeyemi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2024.109236_bib22","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00436-020-06668-6","article-title":"Imidazole derivatives as antiparasitic agents and use of molecular modeling to investigate the structure\u2013activity relationship","volume":"119","author":"Adeyemi","year":"2020","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.compbiomed.2024.109236_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109676","article-title":"The anti-parasite action of imidazole derivatives likely involves oxidative stress but not HIF-1alpha signaling","volume":"349","author":"Adeyemi","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13071-021-04791-6","article-title":"Proteomics analysis reveals that the proto-oncogene eIF-5A indirectly influences the growth, invasion and replication of Toxoplasma gondii tachyzoite","volume":"14","author":"Liu","year":"2021","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.compbiomed.2024.109236_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108745","article-title":"Quercetin promotes antipromastigote effect by increasing the ROS production and anti-amastigote by upregulating Nrf2\/HO-1 expression, affecting iron availability","volume":"113","author":"Cataneo","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.compbiomed.2024.109236_bib26","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/antiox10121872","article-title":"Reactive oxygen species as the brainbox in malaria treatment","volume":"10","author":"Egwu","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.compbiomed.2024.109236_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115927","article-title":"Redox modulating small molecules having antimalarial efficacy","volume":"218","author":"Pal","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"90","key":"10.1016\/j.compbiomed.2024.109236_bib28","doi-asserted-by":"crossref","first-page":"73793","DOI":"10.1039\/C5RA13206A","article-title":"Silver and gold nanoparticles from Sargentodoxa cuneata: synthesis, characterization and antileishmanial activity","volume":"5","author":"Ahmad","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2024.109236_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.exppara.2015.11.004","article-title":"Evidence of reactive oxygen species (ROS) mediated apoptosis in Setaria cervi induced by green silver nanoparticles from Acacia auriculiformis at a very low dose","volume":"160","author":"Saini","year":"2016","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.33640\/2405-609X.3206","article-title":"Imidazole derivative improves antioxidant status and causes differential alteration of redox-status in Drosophila melanogaster","volume":"8","author":"Oluwayemi","year":"2022","journal-title":"Karbala International Journal of Modern Science"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2020.05.059","article-title":"New imidazoles cause cellular toxicity by impairing redox balance, mitochondrial membrane potential, and modulation of HIF-1alpha expression","volume":"529","author":"Adeyemi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep22997","article-title":"Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function","volume":"6","author":"Charvat","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.compbiomed.2024.109236_bib33","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.3390\/ijms22115705","article-title":"Oxidative stress as a possible target in the treatment of toxoplasmosis: perspectives and ambiguities","volume":"22","author":"Szewczyk-Golec","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.109236_bib34","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/molecules28020838","article-title":"Imidazole: synthesis, functionalization and physicochemical properties of a privileged structure in medicinal chemistry","volume":"28","author":"Tolomeu","year":"2023","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.compbiomed.2024.109236_bib35","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1080\/07391102.2022.2139761","article-title":"Elucidation of the anti-plasmodial activity of novel imidazole and oxazole compounds through computational and in vivo experimental approaches","volume":"41","author":"Johnson","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.compbiomed.2024.109236_bib36","first-page":"199","article-title":"Zoonotic disease: new series of imidazoles showed promising growth inhibitory and curative potential against trypanosoma infection","volume":"94","author":"Adeyemi","year":"2021","journal-title":"Yale J. Biol. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jphs.2021.05.004","article-title":"Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2","volume":"147","author":"Johnson","year":"2021","journal-title":"J. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.compbiomed.2024.109236_bib38","doi-asserted-by":"crossref","first-page":"15653","DOI":"10.3390\/molecules191015653","article-title":"Discovery of new imidazole derivatives containing the 2,4-dienone motif with broad-spectrum antifungal and antibacterial activity","volume":"19","author":"Liu","year":"2014","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.compbiomed.2024.109236_bib39","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1017\/S0031182018000562","article-title":"CYP51 as drug targets for fungi and protozoan parasites: past, present and future","volume":"145","author":"Lepesheva","year":"2018","journal-title":"Parasitology"},{"issue":"16","key":"10.1016\/j.compbiomed.2024.109236_bib40","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.compbiomed.2024.109236_bib41","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea derivatives in modern drug discovery and medicinal chemistry","volume":"63","author":"Ghosh","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.109236_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12551-020-00620-9","article-title":"Urea-aromatic interactions in biology","volume":"12","author":"Raghunathan","year":"2020","journal-title":"Biophysical Rev"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524013210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524013210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T21:31:44Z","timestamp":1738359104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482524013210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":42,"alternative-id":["S0010482524013210"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109236","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular modelling and experimental validation identified a new therapeutic inhibitor of toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109236"}}